Company

Covidien

www.medtronic.com/covidien

Covidien was a medical device company acquired by Medtronic in 2015 for $49.9B.

Track Covidien

HQ: Dublin, Ireland
Status: subsidiary

The verified answer

As of Oct 2026, DEPLOY verifies Covidien: 1 model. 1 source back the record.

Models

Overview

Covidien was a medical device company acquired by Medtronic in 2015 for $49.9B. Products included surgical instruments, vascular devices, and respiratory care. Now integrated into Medtronic's portfolio.

Verified record

Verified deployments: None on file
Active incidents: None on file

Valuation of record

DEPLOY VERIFIED

$49.9B (reported, approximate)as of Jan 2015

AcquisitionAcquired by Medtronic

See the full valuations ranking →

Key facts

Dublin, Ireland

Focus

Medical device company

Stage

Acquired by Medtronic

Technology

Surgical and robotic-assist technologies

Status

Acquired by Medtronic 2015 ($49.9B)

Products

Surgical instruments, vascular devices, respiratory care

Data & sources

Web sources

1 source backing this record.View all →

Models (1)

View all models →

Current platform

Covidien Medical Device

Covidien medical device portfolio for surgical and minimally invasive procedures, now part of Medtronic.

otherView model →

Covidien on the deployment map

View the global map

Covidien has no verified deployments on the DEPLOY registry yet. Explore the deployment map by place and type.

Free to use on your site, with a link back to DEPLOY.

The global deployment map →

No verified deployments for Covidien on the DEPLOY record yet. Track Covidien to know the moment the first one is verified.

Current leadership (1)

Geoff Martha Chairman and CEOsecondary-verified

Safety record

No incidents on record for Covidien.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Full safety record: incidents, sourcing, and exposure data →

Recent coverage

Covidien in third-party press

Medtronic has a new global contract manufacturing VP

Sep 10, 2026

Medtronic positions Hugo as ‘another choice’ for surgeons - Medical Design & Outsourcing

Feb 3, 2026

Medtronic Jerusalem unit to lay off 60 - Globes - Israel Business News

Oct 27, 2025

Financial state

Reporting basis: aggregator_estimate
Lifecycle stage: acquired
Counterparty risk class: moderate

Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.

Acquisitions (1)

acquired by Medtronicfull acquisition2014-06-15

Timeline

Every recorded move in Covidien’s history, most recent first: funding rounds, partnerships, acquisitions, supply-chain starts, key hires, and press.

Acquired byAcquired by Medtronic
2014-06-15
Acquired by Medtronic (full_acquisition)

Recent activity

Every change to this record is dated, sourced, and independently verified where marked.

Record createdJun 25, 2026
Added to the verified registry

Full change history →

Sources (1)

https://www.medtronic.com/

Common questions

What is Covidien?

What does Covidien make?

Covidien has 1 robot model on the DEPLOY registry: Covidien Medical Device (Covidien builds physical robots).

Is Covidien publicly traded?

Covidien is not independently listed on public markets; it is part of Medtronic | Technology: Surgical and robotic-assist technologies | Status: Acquired by Medtronic 2015 ($49.9B on the DEPLOY registry.

Who is the CEO of Covidien?

Geoff Martha is the ceo of Covidien, per the DEPLOY registry.

How can I invest in Covidien?

Covidien has no separately traded stock; it is owned by Medtronic | Technology: Surgical and robotic-assist technologies | Status: Acquired by Medtronic 2015 ($49.9B (the parent is the entity that trades, where it is public).

Where is Covidien headquartered?

Covidien is headquartered in Dublin, Ireland.

Who owns Covidien?

Covidien is owned by Medtronic | Technology: Surgical and robotic-assist technologies | Status: Acquired by Medtronic 2015 ($49.9B, per the DEPLOY registry.

Where does Covidien operate robots?

Covidien is a robot manufacturer and does not directly operate deployments on the DEPLOY registry. Its products are deployed by customer operators; see the company page for the verified deployment record.

Is Covidien a top robotics company?

On DEPLOY's intelligence score, which blends verified deployments, funding, hiring, media, safety, and IP signals, Covidien ranks in roughly the top 68% of companies tracked by the registry.

Is Covidien safe?

Covidien has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.

Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-21

Verification posture

Verified

Low confidence

Review state

Stable

Last reviewed 2026-08-21

Sources by quality tier

1: unclassified; Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Covidien

Overview

Key facts

Data & sources

Models (1)

Covidien Medical Device

Covidien on the deployment map

Current leadership (1)

Safety record

Recent coverage

Financial state

Acquisitions (1)

Timeline

Recent activity

Sources (1)

Common questions

In the press

Medtronic has a new global contract manufacturing VP

Medtronic positions Hugo as ‘another choice’ for surgeons - Medical Design & Outsourcing

Medtronic Jerusalem unit to lay off 60 - Globes - Israel Business News

Medtronic to lay off 60 employees at Jerusalem R&D center - calcalistech.com

A breakup or the cusp of greatness? What Medtronic’s big changes mean for its future. - Star Tribune

North Haven targets adding shops and restaurants as Medtronics possibly expands - New Haven Register

Robotic Hernia Repair Surgery Linked To Higher Rates of Hernia Recurrence: Study - AboutLawsuits.com

Another Medtronic EVP is leaving the world’s largest device company - MassDevice

Covidien to Acquire Somanetics Corp. - Medical Device and Diagnostic industry

Medtronic Buys Covidien For $42.9B Underscoring Importance of Scale i - Medical Device and Diagnostic industry

Titan Medical names Cary G. Vance as new president, CEO - MassDevice

The road to a robot: Medtronic’s development process for its Hugo RAS system - MassDevice

Machine-readable surfaces